Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's top companies to splash out 85 bln stg in dividends-study

Mon, 05th Jan 2015 00:00

* FTSE 350 regular dividends seen up 4.4 pct at 75 bln stgin 2015

* Total payouts seen up 11 pct at 85 bln stg excludingVodafone

* Weak oil price may endanger some energy payouts

By Andrew Winterbottom

LONDON, Jan 5 (Reuters) - Britain's biggest companies areset to lavish 85.3 billion pounds ($131 billion) on theirshareholders in 2015 as they drawn on their cash hoards tosupplement regular dividends with additional one-off payouts, astudy said on Monday.

The total level of payouts would be 10.8 percent more thanlast year, excluding Vodafone's return of a $84 billionto shareholders in March 2014 following the approval of the saleof the British company's 45 percent stake in Verizon Wireless.

However that is less than the 18 percent increase in totalpayouts by members of the FTSE 350 index that Markit hadestimated for 2014, again leaving out Vodafone's exceptionallargesse.

Excluding special payouts, ordinary dividends were seen upjust 4.4 percent this year, Markit predicted, saying there was arisk that even this relatively mean overall increase could beimpacted by tough conditions in some big sectors such as oil.

While total regular dividend payments by FTSE 350 membersare set to hit 75.2 billion pounds, fueled in part by investordemand for income in the face of low returns elsewhere, loweroil and iron ore prices meant cash-strapped energy and miningfirms could trim theirs, Markit said.

The firm's average forecast dividend yield for the indexthis year stood at 4.3 percent, though the top five dividendpayers would all exceed 5 percent. Markit noted this returnshowed the appeal of equities given trends elsewhere.

"As the low interest rate environment persists investorscontinue to turn to equities as a source of income," said RyanBransfield, head of UK dividend research at Markit.

Bransfield added that oil majors were likely to cut capitalexpenditure before turning the knife to dividends, but warned ofthe possibility of lower payouts should prices remain low for aprolonged period.

One stand-out performer within the oil and gas sector,however, is John Wood Group, which Markit expects to seeraise its dividend by 25 percent in 2015 thanks to profitsgenerated from its activity in the U.S. shale oil business.

In spite of the potential cuts, the oil and gas sector wasexpected to give back the most to shareholders, at 13.1 billionpounds, followed by healthcare at 10.5 billion and banking at9.3 billion pounds.

In terms of special payments over and above the ordinarydividend payouts, Markit said it expected the pharmaceuticalsand insurance sectors to contribute the most.

Chief among the former is GlaxoSmithKline, set toreturn 4 billion pounds following an expected transaction withNovartis involving its consumer healthcare, vaccinesand oncology businesses in the first half of the year.($1 = 0.6495 British Pounds) (Editing by Simon Jessop and David Holmes)

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.